{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:43:52Z","timestamp":1762098232036},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.nuclcard.2004.12.293","type":"journal-article","created":{"date-parts":[[2005,4,7]],"date-time":"2005-04-07T21:50:54Z","timestamp":1112910654000},"page":"172-178","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Taishiro","family":"Chikamori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Nanasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Toba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunehiko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2004.12.293_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0033-0620(72)90029-1","article-title":"Myocardial utilization of carbohydrate and lipids","volume":"15","author":"Neely","year":"1972","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/S0735-1097(01)01634-5","article-title":"Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain","volume":"38","author":"Kawai","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03164778","article-title":"Resting 123I-BMIPP scintigraphy in diagnosis of effort angina pectoris with reference to subsets of the disease","volume":"12","author":"Yamabe","year":"1998","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib4","first-page":"659","article-title":"Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction","volume":"33","author":"Tamaki","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib5","first-page":"413","article-title":"Phase 3 study of \u03b2-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating fatty acid metabolism","volume":"29","author":"Torizuka","year":"1992","journal-title":"Kakuigaku"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib6","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/01.CIR.101.12.1465","article-title":"Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease","volume":"101","author":"Beller","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib7","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2003.08.011","article-title":"ACC\/AHA\/ASNC guidelines for the clinical use of cardiac radionuclide imaging","volume":"42","author":"Klocke","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib8","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00259-004-1551-8","article-title":"Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction","volume":"31","author":"Matsuki","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib9","first-page":"1747","article-title":"Evaluation of left ventricular function using electrocardiographically gated myocardial SPECT with 123I-labeled fatty acid analog","volume":"42","author":"Nanasato","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0002-9149(02)03314-3","article-title":"Effect of percutaneous coronary angioplasty on myocardial perfusion, function, and wall thickness as assessed by quantitative gated single-photon emission computed tomography","volume":"91","author":"Hida","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0735-1097(95)00218-S","article-title":"Incremental value of prognostic testing in patients with known or suspected ischemic heart disease","volume":"26","author":"Berman","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib12","first-page":"741","article-title":"Guidelines for the diagnosis of hear failure","volume":"16","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.90.1.613","article-title":"Diagnosing and managing unstable angina","volume":"90","author":"Braunwald","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/circ.105.1.5","article-title":"Detection of myocardial ischemia in patients with diabetes mellitus","volume":"105","author":"Wackers","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0735-1097(00)00533-7","article-title":"Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status","volume":"35","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/hc5001.100528","article-title":"Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease","volume":"105","author":"Giri","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0002-8703(88)90492-9","article-title":"Dipyridamole cardiac imaging","volume":"115","author":"Iskandrian","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4065\/70.4.331","article-title":"Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing","volume":"70","author":"Johnston","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0735-1097(98)00057-6","article-title":"Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms","volume":"31","author":"Heller","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF00941855","article-title":"Iodine-123-labeled fatty acids for myocardial SPECT","volume":"22","author":"Knapp","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib22","first-page":"1857","article-title":"Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion","volume":"38","author":"Hosokawa","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib23","first-page":"124","article-title":"Myocardial lipid metabolism in compensated and advanced stages of heart failure","volume":"42","author":"Kataoka","year":"2001","journal-title":"J Nucl Med"},{"issue":"Suppl IV","key":"10.1016\/j.nuclcard.2004.12.293_bib24","first-page":"405","article-title":"Proof of principle study of beta-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) for ischemic memory following demand ischemia [abstract]","volume":"108","author":"Udelson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2004.12.293_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0033-0620(92)90007-M","article-title":"Prognosis in exercise-induced silent myocardial ischemia and implications for screening asymptomatic populations","volume":"34","author":"Cohn","year":"1992","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358104008190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358104008190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nuclcard.2004.12.293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T13:27:11Z","timestamp":1704461231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358104008190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1071358104008190"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2004.12.293","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2004.12.293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society of Nuclear Cardiology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}